期刊文献+

血浆脑钠尿肽及TIMI危险评分对急性心肌梗死患者的预后价值 被引量:5

Prognostic value of brain natriuretic peptide and TIMI risk score in patients with acute myocardial infarction
下载PDF
导出
摘要 目的评估血浆脑钠尿肽(BNP)联合TIMI危险评分对急性心肌梗死(AMI)患者预后价值。方法集中检测连续收入院且随访资料齐全的63例AMI患者血浆BNP,按TIMI危险评分的多个临床资料分析记分,将患者分成不同的危险层次,分析患者BNP水平及TIMI危险评分与患者3个月随访期主要不良心血管事件发生的关系。结果15例复合心血管事件中BNP≥137 pg/ml者占11例,随着BNP水平增高,患者的主要心血管事件发生率也增多,且随着TIMI危险评分值增加而逐渐升高。结论BNP水平和TIMI危险评分越高,临床预后越差。 AIM To evaluate the prognostic value of the combination of brain natriuretic peptide (BNP) and thrombolysis in myocardial infarction (TIMI) risk scoring system in patients with acute myocardial infarction (AMI). METHODS Centralized measurements of BNP were performed after admission in 63 consecutive patients with AMI. TIMI risk scores were calculated from clinical data and risk stratification of patients was conducted according to the scores. The relation of BNP and TIMI risk scores and major adverse cardiovascular events (MACE) from a 3-month follow up were analyzed. RESULTS 11 cases out of the 15 patients with cardiac events were distributed in patients with BNP level over 137 pg/ml. A- mong these high-risk patients, the incidence of MACE increased significantly with the rise of TIMI risk score. CONCLUSION The higher the BNP level and TIMI risk score, the worse the prognosis.
出处 《心脏杂志》 CAS 2007年第1期60-61,64,共3页 Chinese Heart Journal
关键词 脑钠尿肽 TIMI危险评分 心肌梗塞 急性 预后 brain natriuretic peptide TIMI risk score myocardial infarction, Acute prognosis
  • 相关文献

参考文献9

二级参考文献11

  • 1Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient,bedside,clinical score for risk assessment at presentation. An intravenous nPA for treatment of infarcting myocardium early Ⅱ trial substudy. Circulation, 2000, 102:2031-2037.
  • 2Antman EM. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial. Circulation, 1996,94: 911-921.
  • 3Yoshimura M, Yasue H, Morita E, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure [J]. Circulation,1991,84: 1581-1588.
  • 4Langenickel T, Pagel I, Hohnel K, et al. Differential regulation of cardiac ANP and BNP mRNA in different stages of experimental heart failure [J]. Am J Physiol Heart Cire Physiol,2000,278 :H1500-H1506.
  • 5Morita E, Yasue H, Yoshimura M, et al. Increased plasma level of BNP in patients with AMI [J]. J Am Coil Cardiol, 1993,88: 82 - 91.
  • 6Talwar S, Squire IB, Downie PF, et al. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction [J]. Eur Heart J, 2000,21 ( 18 ):1514 - 1521.
  • 7Richards AM, Nicholls MG, Yandle TG, et al. Plasma NT-proBNP and adrenomedulin. New neurohormonal predictors of left ventricular dysfunction and prognosis after myocardial infarction [ J ]. Circulation, 1998,97:1921 - 1929.
  • 8Sabatine MS. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide [ J]. Circulation ,2002,105 ( 15 ): 1760 - 1763.
  • 9Omland T, Persson A, Ng L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes [ J ].Circulation,2002,106: 2913 - 2918.
  • 10臧益民,臧伟进,王晓明.心力衰竭的病理生理机制及治疗概述[J].心脏杂志,2002,14(5):417-419. 被引量:49

共引文献4966

同被引文献18

  • 1丁嵩,何奔.脑钠尿肽在急性冠脉综合征的应用进展[J].心脏杂志,2006,18(1):103-105. 被引量:17
  • 2de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B -type natriuretic peptide in patients with acute coronary syndromes[J].N Engl J Med, 2001,45(14) :1014 -1021.
  • 3James SK, Lindahl B, Siegbahn A, et al. N-terminal probrain natriuretic peptide and other risk factors for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease : a Global Utilization of Strategies To Open occluded arteries ( GUSTO ) -Ⅳ substudy [J]. Circulation, 2003, 108(3) :275 -281.
  • 4[1]Bertrand ME,Simoons ML,Fox KA,et al.Management of acute coronary syndrome:acute coronary syndromes with persistent ST segment elevation;recommendations of the task force of the European society of cardiology.Eur Heart J,2002,21:1406-1432.
  • 5[3]Amman EM,Mccabe CH,Gurfindkel EP,et al.Enoxaparin prevents death and cardiac ischemie events in unstable angina/nonQ wave myocardial infarction.Result of the Thmmbolysis in Myocardial Infarction (TIMI) Ⅱ B trial.Circulation.1999,100:1593-1601.
  • 6[5]Lushcher MS,Thygesen K,Ravkilde J.et al.Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease.Circulation,2003,96:2578-2585.
  • 7[6]Mccullough PA,Omland T,Maise AS.B-type natriuretie peptides:a diagnostic breakthrough for clinicians.Rev Cardiovase Med.2003.4:72-80.
  • 8Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures[J]. N Engl J Med, 1977,297(16) :845 -850.
  • 9Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-type natriuretic peptide as a rapid, point of care test for screening patients undergoing echocardiography to determine left ventricular dysfunction[J]. Am Heart J,2001,141(3) :367 -374.
  • 10Dernellis J, Panaretou M. Assessment of cardiac risk before noncardiac surgery: brain natriuretic peptide in 1590 patients[J]. Heart, 2006,92( 11 ) : 1645 - 1650.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部